Insulin-sensitizing agents in women with polycystic ovary syndrome.
Improvement of insulin resistance and, consequently, hyperinsulinemia is one of the main procedures for treating the polycystic ovary syndrome. The improvement of insulin resistance and the decrease in insulin concentration can be achieved in different ways: (1) by lifestyle modifications; (2) by using insulin sensitizing agents; and (3) by using antiandrogens.
Pasquali
Renato
R
Division of Endocrinology, Department of Internal Medicine, University Alma Mater Studiorum of Bologna, Bologna, Italy. renato.pasquali@unibo.it
Gambineri
Alessandra
A
D000328:Adult; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007333:Insulin Resistance; D008687:Metformin / Q000627:therapeutic use; D011085:Polycystic Ovary Syndrome / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology*; D045162:Thiazolidinediones / Q000627:therapeutic use
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D008687:Metformin